𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genencor celebrates major progress in the conversion of biomass to ethanol

Publisher
Elsevier Science
Year
2004
Weight
36 KB
Volume
2004
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

✦ Synopsis

Quest's ligand technology is being used by Pfizer for the process development and manufacture of new therapeutic compounds. The relationship covers a range of Chiral Quest's catalysts and ligands. This achievement further supports and develops Chiral Quest's goal of becoming a leading, high value technology provider of products and services to the chiral therapeutics industry.

πŸ“œ SIMILAR VOLUMES

Genencor makes strides in the conversion
Genencor makes strides in the conversion of biomass to ethanol
πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science βš– 33 KB

organometallic methods. A test was conducted where a mixture of methane and propane was converted to ethane at 250Β°, with almost 100% selectivity. The results indicated that methane can replace hydrogen to cleave carbon-carbon bonds, saving costs and providing environmental benefits. The new catalys